Formula: | C20H21FN6O |
Molecular Weight: | 380.43 |
Rotatable Bond Donors: | 0 |
clogP: | 2.67 |
Topological Polar Surface Area: | 75.42 |
Lipinski's RO5: | MW: 380.43 HBA: 7 HBD: 1 RB: 0 LogP: 2.67 |
Rule of Three: | MW: 380.43 HBA: 7 HBD: 1 RB: 0 LogP: 2.67 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC145815230 | 1.0 | ZINC145815230 RDKit 3D 28 32 0 0 0 0 0 0 0 0999 V2000 2.0865 4.1861 -0.6224 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3947 2.9582 -1.1688 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.0960 3.1171 -0.9631 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8873 1.8986 -1.4010 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9512 1.5503 -0.3985 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5684 2.5901 0.2223 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.5278 2.2990 1.1318 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9184 1.0117 1.4350 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.8821 0.7780 2.3348 F 0 0 0 0 0 0 0 0 0 0 0 0 -3.3075 -0.0378 0.7728 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3033 0.2179 -0.1666 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6652 -0.9052 -0.9305 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.7043 -1.5756 -1.8200 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4824 -3.0642 -1.6456 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8986 -3.1937 -0.2528 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1634 -1.9571 -0.0480 N 0 0 0 0 0 0 0 0 0 0 0 0 0.1787 -1.9773 0.2880 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7557 -3.1915 0.9807 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0691 -3.1646 1.2441 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8314 -2.0552 0.9022 N 0 0 0 0 0 0 0 0 0 0 0 0 4.1644 -1.8801 1.0698 N 0 0 0 0 0 0 0 0 0 0 0 0 4.3990 -0.6634 0.5742 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2424 -0.0219 0.1021 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2376 -0.9518 0.2950 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9083 -0.9309 -0.0169 N 0 0 0 0 0 0 0 0 0 0 0 0 3.1352 1.2929 -0.4881 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1059 1.9081 -0.9169 O 0 0 0 0 0 0 0 0 0 0 0 0 1.8470 1.7624 -0.5135 N 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 2 3 1 0 3 4 1 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 8 9 1 0 8 10 1 0 10 11 2 0 11 12 1 0 12 13 1 1 13 14 1 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 2 0 19 20 1 0 20 21 1 0 21 22 2 0 22 23 1 0 23 24 2 0 24 25 1 0 23 26 1 0 26 27 2 0 26 28 1 0 28 2 1 0 11 5 1 0 16 12 1 0 25 17 2 0 24 20 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |